Matinas BioPharma’s (MTNB) Hold Rating Reaffirmed at Maxim Group
Matinas BioPharma (NYSEAMERICAN:MTNB – Get Free Report)‘s stock had its “hold” rating reiterated by investment analysts at Maxim Group in a research report issued on Thursday, Benzinga reports. Matinas BioPharma Stock Down 68.1 % MTNB traded down $1.32 during trading on Thursday, hitting $0.62. 2,865,360 shares of the stock were exchanged, compared to its average […]
31 Oct 16:12 · The Cerbat Gem